SEC Form 4 · accession 0001209191-18-004866
TEVA PHARMACEUTICAL INDUSTRIES LTD · TEVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dan S Suesskind
Director
Period of report
Jan 19, 2018
Accepted (ET)
Jan 23, 2018 · 3:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818686
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jan 19, 2018 | H | 19,700 | $25.00 | A | 318,836 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Put Option (Obligation to buy)F1 | $25.00 | Jan 19, 2018 | H | 19,700 | D | Jan 19, 2018 | Jan 19, 2018 | Ordinary Shares | 19,700 | 0 | D |
Explanation of responses
- F1The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.